FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2018/04/013106 [Registered on: 09/04/2018] Trial Registered Retrospectively
Last Modified On: 03/04/2018
Post Graduate Thesis  Yes 
Type of Trial  Observational 
Type of Study   Follow Up Study 
Study Design  Randomized, Parallel Group, Placebo Controlled Trial 
Public Title of Study   A Study To Compare Efficacy Of Dexmedetomidine And Midazolam For Sedation And Reduction Of Dose Of Propofol In Minor Gynaecological Day Care Surgeries 
Scientific Title of Study   A Study To Compare Efficacy Of Dexmedetomidine And Midazolam As Premedicants For Sedation And Propofol Sparing Effect In Minor Gynaecological Day Care Surgeries 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Ruchi Gupta 
Designation  Professor and Head Dept Of Anaesthesia 
Affiliation  Sri Guru Ram Das Medical Colege 
Address  Dept Of Anaesthesiology and Critical Care Sri Guru Ram Das Institute Of Medical Sciences And Research Vallah Amritsar
Dept Of Anaesthesiology and Critical Care Sri Guru Ram Das Institute Of Medical Sciences And Research Vallah Amritsar
Amritsar
PUNJAB
143501
India 
Phone  9814320805  
Fax    
Email  drruchisgrd@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Anita Kumari 
Designation  Professor Dept Of Anaesthesia 
Affiliation  Sri Guru Ram Das Medical Colege 
Address  Dept Of Anaesthesiology and Critical Care Sri Guru Ram Das Institute Of Medical Sciences And Research Vallah Amritsar
Dept Of Anaesthesiology and Critical Care Sri Guru Ram Das Institute Of Medical Sciences And Research Vallah Amritsar
Amritsar
PUNJAB
143501
India 
Phone  9815632909  
Fax    
Email  kumarianitadr1@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Jyoti Vidhan 
Designation  PG Resident 
Affiliation  Sri Guru Ram Das Medical Colege 
Address  Shri Guru Ram Dass Medical College Institute Of Medical Sciences And Research , Dept Of Anaesthesia Vallah , Amritsar
Shri Guru Ram Dass Medical College Institute Of Medical Sciences And Research , Dept Of Anaesthesia Vallah , Amritsar
Amritsar
PUNJAB
146001
India 
Phone  9464091324  
Fax    
Email  vidhanjyoti@gmail.com  
 
Source of Monetary or Material Support  
Shri guru ram dass Medical Institute of health and research  
 
Primary Sponsor  
Name  NA 
Address  NA 
Type of Sponsor  Private medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
Nil  Nil 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Ruchi Gupta   SGRDIMSR  Dept Of Gynaecology And Obstetrics. Sri Guru Ram Das Medical Institute Of Science And reseach. Vallah Amritsa
Amritsar
PUNJAB 
9464091324

drruchisgrd@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Ethic committee SGRDIMSR  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  Gynaecological patients,  
 
Intervention / Comparator Agent  
Type  Name  Details 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  50.00 Year(s)
Gender  Female 
Details  Patients undergoing elective minor gynaecological day care surgeries of <1 hour duration like tubectomy, dilatation & curettage, suction & evacuation, endometrial biopsies, cervical biopsies, polypectomies, cervical stitching etc.  
 
ExclusionCriteria 
Details  1 Patients on alpha adrenergic receptor blocker
2 Patient with known hypersensitivity to study drug
3 Compromised cardiac patients, renal or hepatic disease patients
4 Patients with some psychiatric history.
5 Patients with neurological disease with motor and sensory deficit.
• Patient allergic to egg
• Pregnant patients
 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Participant and Investigator Blinded 
Primary Outcome  
Outcome  TimePoints 
additional dose of propofol required, sedation scores and recovery characteristics.   two hours 
 
Secondary Outcome  
Outcome  TimePoints 
Hemodynamic parameters and side effects of study drug   two hours 
 
Target Sample Size   Total Sample Size="150"
Sample Size from India="150" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   06/04/2016 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="9"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Open to Recruitment 
Publication Details   None Yet 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Brief Summary  

   Ambulatory surgery is  continually evolving speciality in majority of surgical procedures. Dexmedetomidine and midazolam are newer adjuvants for sedation and reducing the dose of anaesthetic agents. Aim of this study was to compare the sedative and propofol sparing effect of dexmedetomidine and midazolam in minor gynaecological day care fitness score were studied as primary outcomes. Hemodynamic parameters and side effects were evaluated as secondary outcomes. Results: Sedation score was statistically highly significant between group A and B (p<0.001). Between group A and C, it was statistically significant (p <0.05), however score was non significant  between groups B and C (p  >0.05). During recovery at 120 minutes after surgery, score 5 was achieved equally by all  three groups which was found to be statistically  insignificant (p > 0.05). Mean dose of additional propofol used, was less in group A (14±9.25) than B (25±5.40) and C (53±10.96). On intergroup comparison between all three groups, it was found to be statistically highly significant (p<0.001). Comparison of BIS values between group A and C and group B and C were highly significant p<0.001. However, it was statistically significant between group A and B (p <0.05). Aldrete scoring and Street Fitness Scores were highly significant between groups A and B, B and C and also between group A and C (p<0.001). No significant hemodynamic derangements and side effects were noted in any of three groups. Conclusion : dexmedetomidine had good sedation and better recovery characteristics than midazolam. BIS monitoring was helpful in maintaining surgeries under BIS monitored general anaesthesia. Material and methods:  a prospective randomized placebo controlled study was conducted on 150 physical status ASA I and II gynaecological patients between 18 to 50 years were allocated into 3 groups of fifty each. Group A received IV dexmedetomidine 0.1 µ.kg-1, group B  received IV midazolam 0.04 mg.kg-1 and group C received normal saline 10 minutes before induction. Observers assessment for activity and sedation score (OAA/S), additional dose of propofol required, recovery characteristics using aldrete and street depth of anesthesia thereby reducing requirement of other anesthetic agents.

 
Close